Due to warehouse inventory, orders placed between Monday, September 17 and Friday, September 21, will be shipped beginning Monday, September 24. The authors explain the use of FNAB in diagnosis of benign processes, common and rare malignant tumors, and occult lesions, as well as in tumor prognostication, treatment planning, and follow-up.
Close attention is given to current criteria for determining the adequacy of the cytologic specimen.
More than 300 illustrations depict the distinguishing cytomorphologic features of various lesions. Two new chapters in this edition address crucial legal concerns such as informed consent and minimizing malpractice risk. All Rights Reserved . Privacy Statement .